Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.
2.

Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists.

Acquas E, Carboni E, Garau L, Di Chiara G.

Psychopharmacology (Berl). 1990;100(4):459-63.

PMID:
2320706
3.

Diazepam-induced place preference conditioning: appetitive and antiaversive properties.

Spyraki C, Kazandjian A, Varonos D.

Psychopharmacology (Berl). 1985;87(2):225-32.

PMID:
3931151
4.
5.

Effects of calcium channel antagonists on the motivational effects of nicotine and morphine in conditioned place aversion paradigm.

Budzynska B, Polak P, Biala G.

Behav Brain Res. 2012 Mar 1;228(1):144-50. doi: 10.1016/j.bbr.2011.12.003. Epub 2011 Dec 11.

PMID:
22178315
6.

Effects of dopamine receptor antagonists on the acquisition of ethanol-induced conditioned place preference in mice.

Pina MM, Cunningham CL.

Psychopharmacology (Berl). 2014 Feb;231(3):459-68. doi: 10.1007/s00213-013-3252-0. Epub 2013 Sep 5.

7.
8.

Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice.

Manzanedo C, Aguilar MA, Rodríguez-Arias M, Miñarro J.

Behav Brain Res. 2001 Jun;121(1-2):189-97.

PMID:
11275296
9.

Morphine-induced place preference in the CXBK mouse: characteristics of mu opioid receptor subtypes.

Suzuki T, Funada M, Narita M, Misawa M, Nagase H.

Brain Res. 1993 Jan 29;602(1):45-52.

PMID:
8383571
10.

Pharmacologic characterization of nicotine-induced conditioned place preference.

Fudala PJ, Teoh KW, Iwamoto ET.

Pharmacol Biochem Behav. 1985 Feb;22(2):237-41.

PMID:
2858867
11.

Motivational effects of opiates in conditioned place preference and aversion paradigm--a study in three inbred strains of mice.

Solecki W, Turek A, Kubik J, Przewlocki R.

Psychopharmacology (Berl). 2009 Dec;207(2):245-55. doi: 10.1007/s00213-009-1672-7. Epub 2009 Sep 29.

PMID:
19787337
12.

A role for the mesolimbic dopamine system in the reinforcing properties of diazepam.

Spyraki C, Fibiger HC.

Psychopharmacology (Berl). 1988;94(1):133-7.

PMID:
3126522
13.

Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists.

Shippenberg TS, Herz A.

Eur J Pharmacol. 1988 Jul 7;151(2):233-42.

PMID:
2844553
14.

Sensitization to the rewarding effects of morphine depends on dopamine.

Manzanedo C, Aguilar MA, Rodríguez-Arias M, Miñarro J.

Neuroreport. 2005 Feb 8;16(2):201-5.

PMID:
15671878
15.

Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats.

Araki H, Kawakami KY, Jin C, Suemaru K, Kitamura Y, Nagata M, Futagami K, Shibata K, Kawasaki H, Gomita Y.

Psychopharmacology (Berl). 2004 Feb;171(4):398-404. Epub 2003 Sep 10.

PMID:
13680070
18.

Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens.

Sellings LH, Baharnouri G, McQuade LE, Clarke PB.

Eur J Neurosci. 2008 Jul;28(2):342-52. doi: 10.1111/j.1460-9568.2008.06341.x.

PMID:
18702705
19.

Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.

Stinus L, Cador M, Zorrilla EP, Koob GF.

Neuropsychopharmacology. 2005 Jan;30(1):90-8.

20.

A test of the opponent-process theory of motivation using lesions that selectively block morphine reward.

Vargas-Perez H, Ting-A-Kee RA, Heinmiller A, Sturgess JE, van der Kooy D.

Eur J Neurosci. 2007 Jun;25(12):3713-8.

PMID:
17610590

Supplemental Content

Support Center